Titan Pharmaceuticals
TTNP
#11017
Rank
ยฃ4.58 M
Marketcap
ยฃ3.45
Share price
-3.76%
Change (1 day)
17.39%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -ยฃ3.38

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ3.28. In 2023 the company made an earnings per share (EPS) of -ยฃ5.54 an increase over its 2022 EPS that were of -ยฃ11.36.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ3.38
2023-ยฃ5.54-51.22%
2022-ยฃ11.36-15.61%
2021-ยฃ13.46-81.37%
2020-ยฃ72.26-77.52%
2019-ยฃ321.50-56.32%
2018-ยฃ736.06-59.51%
2017-ยฃ1,818-371.81%
2016ยฃ668.87-144.35%
2015-ยฃ1,508300%
2014-ยฃ377.01-121.54%
2013ยฃ1,750-151.38%
2012-ยฃ3,407-11.54%
2011-ยฃ3,851188.89%
2010-ยฃ1,333-10%
2009-ยฃ1,481
2007-ยฃ6,072-2.38%
2006-ยฃ6,221-39.13%
2005-ยฃ10,220-16.87%
2004-ยฃ12,293-22.43%
2003-ยฃ15,8484.9%
2002-ยฃ15,10761.9%
2001-ยฃ9,331-13.7%
2000-ยฃ10,81265.01%
1999-ยฃ6,552-35.87%
1998-ยฃ10,218-1824.71%
1997ยฃ592.44-102.4%
1996-ยฃ24,734

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.53-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.25-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-ยฃ3.03-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.69-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ0.18-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ3.19-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA